SCHEMBL25872145

SCHEMBL25872145

COc1cc(N2CCC3(CCN(C(=O)OC(C)(C)C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2N(C)[SH]=O)n1

nearest known ligand 0.66

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 17/20 0.66
▸ EGFR P00533 3/20 0.61
▸ ZAP70 P43403 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25869799 0.94 ALK (0.75) ALKEGFRZAP70
SCHEMBL30497500 0.90 EGFR (0.65) ALKEGFRZAP70
SCHEMBL26500041 0.90 EGFR (0.65) ALKEGFRZAP70
SCHEMBL25869936 0.90 EGFR (0.76) ALKEGFRZAP70
SCHEMBL25871546 0.88 ALK (0.64) ALKEGFRZAP70
SCHEMBL25872847 0.87 ALK (0.63) ALKEGFRZAP70
SCHEMBL25872148 0.87 ALK (0.73) ALKEGFR
SCHEMBL25872232 0.87 ALK (0.59) ALKEGFR
SCHEMBL30497488 0.84 ALK (0.74) ALKEGFRZAP70
SCHEMBL29059678 0.84 ALK (0.74) ALKEGFRZAP70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4212522-A1 COMPOUNDS FOR SUPPRESSING EGFR MUTANT CANCER AND PHARMACEUTICAL USE THEREOF J2H Biotech Inc. (KR) 2023-07-19 — — EP disclosed
Send feedback